The reality of the situation here is we.have just proven still early but proven we will be able to treat these horrible diseases Wich happens to be. A 30 billion dollar market . A JV is coming let's not be stupid here its coming I believe if that 35 year old in England gets vision back and he will he is probably starting to see better already its been over. Week then we get our JV watch and learn
I loved the previous message which started out as "We restored a goodly amount of vision". The "we" implies that by owning this stock we are part of the solution. Great attitude. Funny that I never thought of it in that way.
if his condition was as bad as that of the previous patients, there is a big change he will now be able starting counting his fingers using his treated eye. Likely, within about two weeks his vision will be improved to 20/800. This all as a 'low dose side effect' of the safety trial. ACTC still has a long way to go, but hé isn't it exiting? Been investing in ACTC since 2008, its bumpy but getting there.